T1	Or 30 32	or
E1	Or:T1 Arg:T83 Arg2:T84
T2	Eq-Comparison 48 72	18 years of age or older
E2	Eq-Comparison:T2 Value:T85 Temporal-Unit:T86 Operator:T87
T3	Eq-Comparison 92 110	moderate to severe
E3	Eq-Comparison:T3 Operator:T89 Value:T88 Value2:T90
T4	Condition 111 114	DLE
E4	Condition:T4 Name:T91 Severity:T90
T5	And 115 119	with
E5	And:T5 Arg:E4 Arg2:E8
T6	Eq-Comparison 120 132	at least one
E6	Eq-Comparison:T6 Operator:T92 Value:T93
T7	Eq-Comparison 133 139	active
E7	Eq-Comparison:T7 Temporal-Period:T94
T8	Condition 155 161	lesion
E8	Condition:T8 Name:T95 Minimum-Count:E6 Temporality:E7
T9	Eq-Comparison 163 174	0.5-1.0 cm2
E9	Eq-Comparison:T9 Value:T96 Operator:T97 Value:T98 Unit:T99
T10	And 177 181	with
E10	And:T10 Arg:E8 Arg2:E11
T11	Observation 182 187	CLASI
E11	Observation:T11 Name:T100 Eq-Comparison:E12
T12	Eq-Comparison 188 191	≥ 5
E12	Eq-Comparison:T12 Operator:T101 Value:T143
T13	Assertion 198 209	Willingness
E13	Assertion:T13 Asserted:E14
A1	Assertion-Type-Value E13 hypothetical
T14	Study 235 240	study
E14	Study:T14 Study-Of:E86
T15	Assertion 257 271	Willingness to
E15	Assertion:T15 Asserted:E87
A2	Assertion-Type-Value E15 hypothetical
T16	Condition 300 308	diseased
E16	Condition:T16 Name:T146
T17	Modifier 318 325	natural
E17	Modifier:T17 Modifies:T146
T18	Or 326 328	or
E18	Or:T18 Arg:E17 Arg2:E19
T20	Condition 374 383	Pregnancy
E20	Condition:T20 Name:T102
T21	Or 384 386	or
E21	Or:T21 Arg:E20 Arg2:E22
T22	Condition 387 401	breast feeding
E22	Condition:T22 Name:T103
T23	Condition 411 420	condition
E23	Condition:T23 
T24	Or 421 423	or
E24	Or:T24 Arg:E23 Arg2:E25
T25	Procedure 424 431	therapy
E25	Procedure:T25 Name:T104
T26	Assertion 467 470	may
E26	Assertion:T26 Asserted:T27
A3	Assertion-Type-Value E26 hypothetical
T28	Risk 478 482	risk
E28	Risk:T28 Stability:T27
T29	Assertion 506 511	could
E29	Assertion:T29 Asserted:T105
A4	Assertion-Type-Value E29 hypothetical
T30	Study 549 554	study
E30	Study:T30 Stability:T105
T31	Modifier 560 568	Systemic
E31	Modifier:T31 Modifies:T106
T32	Condition 569 588	Lupus Erythematosus
E32	Condition:T32 Name:T106
T33	Condition 590 593	SLE
E33	Condition:T33 Name:T107
T35	Condition 633 649	hypersensitivity
E35	Condition:T35 Name:T109
T36	Coreference 664 676	constituents
E36	Coreference:T36 Refers-To:E40
T37	Or 677 679	or
E37	Or:T37 Arg:E36 Arg2:E38
T38	Coreference 680 690	excipients
E38	Coreference:T38 Refers-To:E40
T39	Study 698 713	investigational
E39	Study:T39 Study-Of:E40
T40	Drug 714 721	product
E40	Drug:T40 
T41	Modifier 738 750	prescription
E41	Modifier:T41 Modifies:E44
T42	Or 751 753	or
E42	Or:T42 Arg:E41 Arg2:E43
T43	Negation 754 757	non
E43	Negation:T43 Negates:E88
T44	Drug 771 781	medication
E44	Drug:T44 Temporality:E34
T45	Assertion 787 792	could
E45	Assertion:T45 Asserted:T112
A5	Assertion-Type-Value E45 hypothetical
T46	Procedure 808 828	efficacy evaluations
E46	Procedure:T46 Name:T111 Stability:T112
T47	Study 836 841	study
E47	Study:T47 Study-Of:E46
T48	Modifier 864 872	systemic
E48	Modifier:T48 Modifies:T114
T49	Procedure 873 884	DLE therapy
E49	Procedure:T49 Name:T114 Stability:T113 Temporality:E54
T50	Drug 891 915	systemic corticosteroids
E50	Drug:T50 Name:T115
T51	Drug 917 931	cyclosporine A
E51	Drug:T51 Name:T116
T52	Drug 933 945	azathioprine
E52	Drug:T52 Name:T117
T53	Drug 947 968	mycophenolate mofetil
E53	Drug:T53 Name:T118
T54	Eq-Comparison 977 989	past 1 month
E54	Eq-Comparison:T54 Temporal-Period:T119 Value:T120 Temporal-Unit:T121
T55	Eq-Comparison 996 999	Use
E55	Eq-Comparison:T55 Temporal-Period:T122
T56	Modifier 1003 1011	systemic
E56	Modifier:T56 Modifies:T123
T57	Condition 1012 1016	pain
E57	Condition:T57 Name:T123 Temporality:E55
T58	Drug 1017 1028	medications
E58	Drug:T58 Temporality:E60
T59	Drug 1035 1044	oxycodone
E59	Drug:T59 Name:T125
T60	Eq-Comparison 1052 1064	past 2 weeks
E60	Eq-Comparison:T60 Temporal-Period:T126 Value:T127 Temporal-Unit:T128
T61	Other 1087 1094	another
E61	Other:T61 Is-Other:E62
T62	Study 1113 1118	study
E62	Study:T62 
T63	Study 1127 1142	investigational
E63	Study:T63 Study-Of:E64
T64	Drug 1143 1147	drug
E64	Drug:T64 Temporality:E65
T65	Eq-Comparison 1148 1162	within 4 weeks
E65	Eq-Comparison:T65 Operator:T129 Value:T130 Temporal-Unit:T131
T66	Temporal-Connection 1163 1169	before
E66	Temporal-Connection:T66 Arg:E65 Arg2:E67
A6	Temporal-Connection-Type-Value E66 before
T67	Study 1175 1180	study
E67	Study:T67 
T68	Eq-Comparison 1186 1189	Use
E68	Eq-Comparison:T68 Temporal-Period:T132
T69	Drug 1193 1211	immune-suppressant
E69	Drug:T69 Name:T133 Temporality:E68
T70	Or 1212 1214	or
E70	Or:T70 Arg:E69 Arg2:E72
T71	Other 1215 1220	other
E71	Other:T71 Is-Other:E72
T72	Procedure 1221 1241	biological treatment
E72	Procedure:T72 Name:T148
T73	Eq-Comparison 1247 1255	Starting
E73	Eq-Comparison:T73 Temporal-Period:T134
T74	Drug 1256 1277	antimalarial medicine
E74	Drug:T74 Name:T135 Temporality:E73
T75	Temporal-Connection 1278 1283	after
E75	Temporal-Connection:T75 Arg:E74 Arg2:E76
A7	Temporal-Connection-Type-Value E75 after
T76	Study 1301 1306	study
E76	Study:T76 
T77	Drug 1353 1365	antimalarial
E77	Drug:T77 Name:T137 Temporality:E90 Stability:T136
T78	Temporal-Connection 1366 1372	before
E78	Temporal-Connection:T78 Arg:E77 Arg2:E79
A8	Temporal-Connection-Type-Value E78 before
T79	Study 1373 1383	enrollment
E79	Study:T79 
T81	Eq-Comparison 1421 1428	ongoing
E81	Eq-Comparison:T81 Temporal-Period:T138
T82	Condition 1429 1438	infection
E82	Condition:T82 Name:T139 Temporality:E81
T83	Life-Stage-And-Gender 25 29	Male
A10	Life-Stage-And-Gender-Type T83 male
T84	Life-Stage-And-Gender 33 39	female
A11	Life-Stage-And-Gender-Type T84 female
T85	Eq-Value 48 50	18
T86	Eq-Temporal-Unit 51 56	years
A12	Eq-Temporal-Unit-Value T86 year
T87	Eq-Operator 64 72	or older
A13	Eq-Operator-Value T87 GTEQ
T88	Severity 92 100	moderate
A14	Severity-Value T88 moderate
T89	Eq-Operator 101 103	to
A15	Eq-Operator-Value T89 BETWEEN
T90	Severity 104 110	severe
A16	Severity-Value T90 severe
T91	Condition-Name 111 114	DLE
T92	Eq-Operator 120 128	at least
A17	Eq-Operator-Value T92 GTEQ
T93	Eq-Value 129 132	one
T94	Eq-Temporal-Period 133 139	active
A18	Eq-Temporal-Period-Value T94 present
T95	Condition-Name 155 161	lesion
T96	Eq-Value 163 166	0.5
T97	Eq-Operator 166 167	-
A19	Eq-Operator-Value T97 BETWEEN
T98	Eq-Value 167 170	1.0
T99	Eq-Unit 171 174	cm2
T100	Observation-Name 182 187	CLASI
T101	Eq-Operator 188 189	≥
A20	Eq-Operator-Value T101 GTEQ
T102	Condition-Name 374 383	Pregnancy
T103	Condition-Name 387 401	breast feeding
T104	Procedure-Name 424 431	therapy
T105	Stability 512 521	interfere
A21	Stability-Value T105 change
T106	Condition-Name 569 588	Lupus Erythematosus
T107	Condition-Name 590 593	SLE
T109	Condition-Name 633 649	hypersensitivity
T110	Eq-Temporal-Period 727 730	Use
A22	Eq-Temporal-Period-Value T110 present
T112	Stability 793 802	interfere
A23	Stability-Value T112 change
T113	Stability 847 853	Change
A24	Stability-Value T113 change
T114	Procedure-Name 873 884	DLE therapy
T115	Drug-Name 891 915	systemic corticosteroids
T116	Drug-Name 917 931	cyclosporine A
T117	Drug-Name 933 945	azathioprine
T118	Drug-Name 947 968	mycophenolate mofetil
T119	Eq-Temporal-Period 977 981	past
A25	Eq-Temporal-Period-Value T119 past
T120	Eq-Value 982 983	1
T121	Eq-Temporal-Unit 984 989	month
A26	Eq-Temporal-Unit-Value T121 month
T122	Eq-Temporal-Period 996 999	Use
A27	Eq-Temporal-Period-Value T122 present
T123	Condition-Name 1012 1016	pain
T125	Drug-Name 1035 1044	oxycodone
T126	Eq-Temporal-Period 1052 1056	past
A28	Eq-Temporal-Period-Value T126 past
T127	Eq-Value 1057 1058	2
T128	Eq-Temporal-Unit 1059 1064	weeks
A29	Eq-Temporal-Unit-Value T128 week
T129	Eq-Operator 1148 1154	within
A30	Eq-Operator-Value T129 LTEQ
T130	Eq-Value 1155 1156	4
T131	Eq-Temporal-Unit 1157 1162	weeks
A31	Eq-Temporal-Unit-Value T131 week
T132	Eq-Temporal-Period 1186 1189	Use
A32	Eq-Temporal-Period-Value T132 present
T133	Drug-Name 1193 1211	immune-suppressant
T134	Eq-Temporal-Period 1247 1255	Starting
A33	Eq-Temporal-Period-Value T134 present
T135	Drug-Name 1256 1277	antimalarial medicine
T136	Stability 1338 1344	stable
A34	Stability-Value T136 stable
T137	Drug-Name 1353 1365	antimalarial
T138	Eq-Temporal-Period 1421 1428	ongoing
A35	Eq-Temporal-Period-Value T138 present
T139	Condition-Name 1429 1438	infection
T140	Age 60 63	age
E83	Age:T140 Eq-Comparison:E2
T141	Modifier 140 154	discoid target
E84	Modifier:T141 Modifies:T95
T142	Observation 155 161	lesion
E85	Observation:T142 Eq-Comparison:E9
T143	Eq-Value 190 191	5
T144	Procedure 241 251	procedures
E86	Procedure:T144 
T145	Negation 272 277	avoid
E87	Negation:T145 Negates:E16
T19	Modifier 329 348	artificial sunlight
E19	Modifier:T19 Modifies:T146
T146	Condition-Name 300 308	diseased
T27	Stability 471 475	pose
A36	Stability-Value T27 change
R1	Caused-By Arg1:T27 Arg2:E23	
R2	Caused-By Arg1:T27 Arg2:E25	
T147	Or 498 500	or
E27	Or:T147 Arg:E28 Arg2:E29
R3	Abbrev-Of Arg1:E33 Arg2:E32	
R4	Caused-By Arg1:E35 Arg2:E36	
R5	Caused-By Arg1:E35 Arg2:E38	
T34	Eq-Comparison 727 730	Use
E34	Eq-Comparison:T34 Temporal-Period:T110
T108	Modifier 758 770	prescription
E88	Modifier:T108 Modifies:E44
R6	Caused-By Arg1:T112 Arg2:E44	
T111	Procedure-Name 808 828	efficacy evaluations
R7	Example-Of Arg1:E50 Arg2:E49	
R8	Example-Of Arg1:E51 Arg2:E49	
R9	Example-Of Arg1:E52 Arg2:E49	
R10	Example-Of Arg1:E53 Arg2:E49	
R11	Treatment-For Arg1:E58 Arg2:E57	
R12	Example-Of Arg1:E59 Arg2:E58	
T124	And 1119 1123	with
E89	And:T124 Arg:E62 Arg2:E64
T148	Procedure-Name 1221 1241	biological treatment
T149	Eq-Comparison 1325 1332	already
E90	Eq-Comparison:T149 Temporal-Period:T150
T150	Eq-Temporal-Period 1325 1332	already
A37	Eq-Temporal-Period-Value T150 past
